Scientific Program

Friday, November 4, 2022
10:30-15:30 Central European Time (CET)
10:30 Welcome Note
Yuval Yaron, Israel
10:30-11:00 Sponsored symposium- Illumina
11:00-12:30 Session 1: Advances in Prenatal Diagnosis
11:00-11:30 Prenatal ES for the investigation of congenital malformations: the UK experience
Mark Kilby, UK
11:30-12:00 Prenatal Exome and Genome Sequencing: Pros and Cons of Each Method in Prenatal Diagnosis
Neeta Vora, USA
12:00-12:30 Genetics of fetal growth restriction
Toni Borrell, Catalunya
12:30-13:30 Sponsored symposium- Perkin Elmer
13:30-15:30 Session 2: Non-Invasive Prenatal testing
13:30-14:00 The usage of NIPT in the UK
Pranav P Pandya, UK
14:00-14:30 Cell-based NIPT: a new approach for prenatal testing
Francesca Romana Grati, Italy
14:30-15:00 cfDNA testing: the more the better?
Liona Poon, Hong Kong
15:00-15:30 CLIA lab experience with non-invasive Single Cell Prenatal Diagnosis
Art Beaudet, LunaGenetics, USA
Saturday, November 5, 2022
10:30-15:30 Central European Time (CET)
10:30-11:00 TBA
11:00-14:30 Session 3: Preimplantation genetic testing (PGT)
Moderator: Avner Hershlag, USA
11:00-11:30 The developmental and chromosomal landscape of human embryonic arrest
Christian Ottolini, UK
11:30-12:00 Is PGT always right?
Tony Gordon, UK
12:00-12:30 Cell-free PGTa – better genomic accuracy?
Svetlana Madjunkova, Canada
12:30-13:00 The next chapter for PGT-M: De Novo mutations
Martine De Rycke, Belgium
13:00-13:30 Can PGT-M prevent serious polygenic disease?
Nathan Treff, USA
13:30-14:00 Replacement of defective genes: an alternative to PGT-M?
Dagan Wells, UK
14:30-15:00 Congress summary and Highlights
Yuval Yaron, Israel